Orthofix International | OFIX - Gross Profit On Sales


Orthofix International reported $153.28M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
EDAP TMS EUR 5.97M 850K Sep/2025
Globus Medical USD 496.26M 39.69M Mar/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
J&J USD 17.24B 642M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Stryker USD 3.81B 675M Mar/2026
Surmodics USD 20.08M 31.62M Jun/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Veracyte USD 101.16M 814K Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025